These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 17390065

  • 1. The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.
    Okano J, Nagahara T, Matsumoto K, Murawaki Y.
    Oncol Rep; 2007 May; 17(5):1195-200. PubMed ID: 17390065
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K, Okano J, Nagahara T, Murawaki Y.
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [Abstract] [Full Text] [Related]

  • 3. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I.
    Cancer Res; 2009 Oct 01; 69(19):7595-602. PubMed ID: 19773433
    [Abstract] [Full Text] [Related]

  • 4. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
    Okano J, Nagahara T, Matsumoto K, Murawaki Y.
    Basic Clin Pharmacol Toxicol; 2008 Jun 01; 102(6):543-51. PubMed ID: 18346049
    [Abstract] [Full Text] [Related]

  • 5. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ, Cho YH, Park K, Kim EJ, Jung KH, Park SS, Kim WJ, Moon SK.
    Biochem Pharmacol; 2008 Jun 15; 75(12):2289-300. PubMed ID: 18468578
    [Abstract] [Full Text] [Related]

  • 6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 15; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 7. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST.
    Carcinogenesis; 2008 Nov 15; 29(11):2096-105. PubMed ID: 18765415
    [Abstract] [Full Text] [Related]

  • 8. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM.
    J Surg Res; 2008 Dec 15; 150(2):219-26. PubMed ID: 18468633
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
    Sutter AP, Maaser K, Höpfner M, Huether A, Schuppan D, Scherübl H.
    J Hepatol; 2005 Nov 15; 43(5):808-16. PubMed ID: 16083991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
    Liang RR, Zhang S, Qi JA, Wang ZD, Li J, Liu PJ, Huang C, Le XF, Yang J, Li ZF.
    Int J Oncol; 2012 Sep 15; 41(3):969-78. PubMed ID: 22684543
    [Abstract] [Full Text] [Related]

  • 13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 15; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E, Lee KY.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):771-9. PubMed ID: 14975768
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
    Dziadyk JM, Sui M, Zhu X, Fan W.
    Anticancer Res; 2004 Mar 12; 24(1):27-36. PubMed ID: 15015572
    [Abstract] [Full Text] [Related]

  • 16. ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells.
    Suyama H, Igishi T, Sano H, Matsumoto S, Shigeoka Y, Nakanishi H, Endo M, Burioka N, Hitsuda Y, Shimizu E.
    Int J Oncol; 2004 Jun 12; 24(6):1499-504. PubMed ID: 15138593
    [Abstract] [Full Text] [Related]

  • 17. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO, Kim MO, Kang SH, Lee KJ, Heo MS, Choi KS, Choi YH, Kim GY.
    Biochem Pharmacol; 2008 Aug 01; 76(3):312-21. PubMed ID: 18571148
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS).
    Lu KH, Lue KH, Chou MC, Chung JG.
    J Orthop Res; 2005 Sep 01; 23(5):988-94. PubMed ID: 16140185
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.